Hepatocellular Carcinoma

• CLINICAL_TRIALS trial_result · 2020-04-22
  Clinical Trial Update: Sorafenib + mFOLFOX for Hepatocellular Carcinoma [Phase 2]

  Phase 2 trial evaluating sorafenib in combination with mFOLFOX for hepatocellular carcinoma has completed with results posted.

• CLINICAL_TRIALS trial_result · 2020-04-20
  Clinical Trial Update: Phase 1-2 Trial HCQ Plus TACE in Unresectable HCC [Phase 1, Phase 2]

  Phase 1-2 trial evaluating hydroxychloroquine plus transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma was termi…

• CLINICAL_TRIALS trial_result · 2020-04-16
  Clinical Trial Update: Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy [Phase 2, Phase 3]

  Phase 2/3 trial evaluating autologous immune killer cells as an adjunct therapy for liver cancer (hepatocellular carcinoma).

• CLINICAL_TRIALS trial_result · 2020-04-10
  Clinical Trial Update: Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 2]

  Phase 2 trial comparing SECOX to Sorafenib as first-line therapy in advanced hepatocellular carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2020-04-10
  Clinical Trial Update: A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC [Phase 3]

  A Phase 3 trial evaluating transarterial chemoembolization (TACE) with and without external beam radiotherapy (EBRT) for advanced hepatocell…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2020-04-09
  Clinical Trial Update: SECOX as Neoadjuvant Therapy in Patients With Locally Advanced HCC [Phase 2]

  Phase 2 clinical trial evaluating SECOX as neoadjuvant therapy for locally advanced hepatocellular carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2020-04-03
  Clinical Trial Update: A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma [Phase 2]

  Phase 2 trial update for GC33 (RO5137382) in advanced or metastatic hepatocellular carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2020-04-03
  Clinical Trial Update: Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma [Phase 2]

  Phase 2 trial update on anlotinib after lenvatinib in hepatocellular carcinoma patients; current status is unknown.

• CLINICAL_TRIALS trial_result · 2020-03-25
  Clinical Trial Update: Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC [Phase 3]

  Phase 3 trial evaluating sorafenib plus TACE versus sorafenib alone as postoperative adjuvant treatment for resectable primary advanced hepa…

• CLINICAL_TRIALS trial_result · 2020-03-25
  Clinical Trial Update: Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection [Phase 3]

  Phase 3 clinical trial evaluating postoperative antimicrobial prophylaxis versus placebo for infection prevention in hepatocellular carcinom…

• CLINICAL_TRIALS trial_result · 2020-03-24
  Clinical Trial Update: Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver Transplantation [Phase 3]

  A Phase 3 clinical trial evaluating relenvatinib for treating recurrence of hepatocellular carcinoma after liver transplantation is listed, …

• CLINICAL_TRIALS trial_result · 2020-03-24
  Clinical Trial Update: Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus [Phase 2, Phase 3]

  Clinical trial update for lenvatinib after liver transplantation in patients with hepatocellular carcinoma and portal vein tumor thrombus (P…

• CLINICAL_TRIALS trial_result · 2020-03-03
  Clinical Trial Update: Stereotactic Body Radiotherapy for Liver Tumors [NA]

  Clinical trial update on stereotactic body radiotherapy for liver tumors has completed with posted results.

• CLINICAL_TRIALS trial_result · 2020-02-17
  Clinical Trial Update: Study of Pembrolizumab (MK-3475) vs. Best Supportive Care in Participants With Previously Systemically Treated Advanced Hepatocellular Carcinoma (MK-3475-240/KEYNOTE-240) [Phase 3]

  Phase 3 trial of pembrolizumab vs best supportive care in previously treated advanced hepatocellular carcinoma completed; results posted in …

• CLINICAL_TRIALS trial_result · 2020-02-17
  Clinical Trial Update: PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC [Phase 2]

  Phase 2 trial evaluating a PD-1 monoclonal antibody, lenvatinib, and transarterial chemoembolization (TACE) for non-resectable hepatocellula…

• CLINICAL_TRIALS trial_result · 2020-02-11
  Clinical Trial Update: Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection [Phase 3]

  Phase 3 clinical trial evaluating sorafenib for hepatocellular carcinoma with microvascular invasion after radical resection has been termin…

• CLINICAL_TRIALS trial_result · 2020-02-11
  Clinical Trial Update: Transcatheter Arterial Chemoembolization Combined With Sorafenib for Unresectable Hepatocellular Carcinoma [Phase 3]

  Phase 3 trial evaluating transcatheter arterial chemoembolization combined with sorafenib in unresectable hepatocellular carcinoma has compl…

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma [Phase 4]

  A Phase 4 clinical trial investigating the combination of sorafenib with TACE in hepatocellular carcinoma guided by GALNT14 genotype.

• CLINICAL_TRIALS trial_result · 2020-02-05
  Clinical Trial Update: IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients [Phase 1, Phase 2]

  Phase 1/2 trial update for IMA970A plus CV8102 in very early to intermediate hepatocellular carcinoma has completed enrollment.

• CLINICAL_TRIALS trial_result · 2020-01-27
  Clinical Trial Update: Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCC [Phase 2]

  Phase 2 clinical trial assessing lenvatinib as a conversion therapy for hepatocellular carcinoma (HCC) with efficacy and safety outcomes.

• CLINICAL_TRIALS trial_result · 2020-01-22
  Clinical Trial Update: An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects [Phase 2]

  Phase 2 trial update of an individualized anti-cancer vaccine in adults with advanced hepatocellular carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2020-01-22
  Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery [NA]

  A completed clinical trial evaluating stereotactic body radiation therapy for patients with unresectable hepatocellular carcinoma, with resu…

• CLINICAL_TRIALS trial_result · 2020-01-18
  Clinical Trial Update: Sorafenib Combined With Arsenical in Treating Patients With Recurrent HCC After Liver Transplantation [Phase 2]

  Phase 2 clinical trial evaluating sorafenib plus arsenic-based treatment for recurrent hepatocellular carcinoma after liver transplantation.

• CLINICAL_TRIALS trial_result · 2020-01-14
  Clinical Trial Update: Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular Carcinoma [Phase 2]

  Phase 2 trial update evaluating lenvatinib as adjuvant therapy for hepatocellular carcinoma, focusing on efficacy and safety outcomes.

• CLINICAL_TRIALS trial_result · 2020-01-10
  Clinical Trial Update: Adjuvant Therapies for Patients With HCC and MVI [Phase 3]

  Phase 3 clinical trial update on adjuvant therapies for hepatocellular carcinoma with microvascular invasion (HCC with MVI).